OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT1: a potential tumour biomarker and therapeutic target
Bin Zhao, Xin Li, Liangfu Zhou, et al.
Journal of drug targeting (2019) Vol. 27, Iss. 10, pp. 1046-1052
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway
Haixiu Liao, Meng Ding, Nannan Zhou, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 3
Open Access | Times Cited: 25

The role of epigenetic modification in postoperative cognitive dysfunction
Wei-Feng Wu, Jia-Tao Lin, Yongkang Qiu, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101983-101983
Closed Access | Times Cited: 16

LncRNA GAS5 suppresses inflammatory responses by inhibiting HMGB1 release via miR-155-5p/SIRT1 axis in sepsis
Zhuo Zeng, Yingying Lan, Yu Chen, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175520-175520
Closed Access | Times Cited: 13

Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
Agata Poniewierska-Baran, Paulina Warias, Katarzyna Zgutka
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15119-15119
Open Access | Times Cited: 15

Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity
Shuang‐Shuang Yu, Rong-Chun Tang, Ao Zhang, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 2

Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells
Jun Wang, Xi Liu, Yuanfeng Huang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10

A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function
Xiuxin Han, Mengfan Yin, Gong Chen, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 1017-1029
Closed Access | Times Cited: 6

Fenofibrate inhibits hypoxia‐inducible factor‐1 alpha and carbonic anhydrase expression through activation of AMP‐activated protein kinase/HO‐1/Sirt1 pathway in glioblastoma cells
Chingju Lin, Sheng‐Wei Lai, Ching‐Kai Shen, et al.
Environmental Toxicology (2021) Vol. 36, Iss. 12, pp. 2551-2561
Closed Access | Times Cited: 14

Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis
John Maringa Githaka, Leila Pirayeshfard, Ing Swie Goping
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 8, pp. 130375-130375
Open Access | Times Cited: 5

Sirt1 gene confers Adriamycin resistance in DLBCL via activating the PCG-1α mitochondrial metabolic pathway
Zhen Zhou, Dan Ma, Peifan Li, et al.
Aging (2020) Vol. 12, Iss. 12, pp. 11364-11385
Open Access | Times Cited: 13

MDM2-dependent Sirt1 degradation is a prerequisite for Sirt6-mediated cell death in head and neck cancers
Jung Je Park, Young‐Sool Hah, Somi Ryu, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 3, pp. 422-431
Open Access | Times Cited: 10

Diverse alkaloids from the aerial parts of Aconitum carmichaelii and antiproliferative activity of costemline via inhibiting SIRT1/ROCK1/P-STAT3 pathways
Yinlin Zhou, Duan-Na Zhang, Ji-Xu Qiao, et al.
Phytochemistry (2022) Vol. 207, pp. 113558-113558
Closed Access | Times Cited: 7

Apoptotic Effect of Isoimpertorin via Inhibition of c-Myc and SIRT1 Signaling Axis
Hwan‐Joo Ko, Suyeon Park, Deok Yong Sim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4248-4248
Open Access | Times Cited: 1

Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells
Anna Wawruszak, Estera Okoń, Ilona Telejko, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 5, pp. 1011-1024
Open Access | Times Cited: 6

FOXO6 transcription inhibition of CTRP3 promotes OGD/R-triggered cardiac microvascular endothelial barrier disruption via SIRT1/Nrf2 signalling
Sanfu Zheng, Yu Wang, Weixi Guo, et al.
Folia Morphologica (2023) Vol. 83, Iss. 1, pp. 125-138
Open Access | Times Cited: 3

CircHULC accelerates the growth of human liver cancer stem cells by enhancing chromatin reprogramming and chromosomal instability via autophagy
Shuting Song, Liyan Wang, Xiaoxue Jiang, et al.
Cellular Signalling (2023) Vol. 109, pp. 110772-110772
Closed Access | Times Cited: 3

MicroRNA-29 regulates tumor progression and survival through miR-29a-SIRT1-Wnt/β-catenin pathway in hepatocellular carcinoma
Liqiang Qian, Yanjun Zhang, Gang Wang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2

miR-29a-SIRT1-Wnt/β-Catenin Axis Regulates Tumor Progression and Survival in Hepatocellular Carcinoma
Liqiang Qian, Yanjun Zhang, Gang Wang, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 3, pp. 1895-1913
Open Access | Times Cited: 2

SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas
Emilia Białopiotrowicz, Monika Noyszewska‐Kania, Ewa Jabłońska, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 1

Emerging therapeutic strategy for mitigating cancer progression through inhibition of sirtuin-1 and epithelial-mesenchymal transition
Nahla E. El‐Ashmawy, Eman G. Khedr, Naglaa F. Khedr, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154907-154907
Closed Access | Times Cited: 1

Sirt6-Mediated Cell Death Associated with Sirt1 Suppression in Gastric Cancer
Ji‐Hyun Seo, Somi Ryu, So Young Cheon, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 387-387
Open Access

Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration
X Wang, Fangqi Deng, Jie-Xi Liu, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 912-922
Open Access

Preclinical evaluation of pharmacological inhibition of SIRT1 on the growth of tumoral and metastatic granulosa cells
Victoria Cluzet, Éloïse Airaud, Marie M. Devillers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1
Jiawei Chen, Kebin Chen, Shuai Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top